Evidence map

ArticleFrontiers in oncology2023

Metformin is a metabolic modulator and radiosensitiser in rectal cancer.

Croí E Buckley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37601689